Accueil・Liste d'Actions・Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Fermé

SecteurSoins de santé

1.56 11.43

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.3900000000000001

Max

1.47

Chiffres clés
By Trading Economics
Revenu	-45M -53M
Ventes	1.8M 39M
BPA	-0.14
Marge bénéficiaire	-135.914
Employés	485
EBITDA	-32M -38M

Recommandations
By TipRanks
Recommandations	Neutre
Prévisions sur 12 Mois	+34.75% upside

Dividendes
By Acuity
Prochains Résultats	4 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-18M 423M
Ouverture précédente	-9.87
Clôture précédente	1.56

Sentiment de l'Actualité

By Acuity

50%

128 / 339 Classement par Healthcare

Pacific Biosciences of California Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 sept. 2026, 20:07 UTC

Correlated Moves

Pacific Biosciences is sharply lower, following a broader market decline and significant losses in key holdings of the ARK Genomic Revolution ETF.

22 sept. 2026, 23:06 UTC

Pacific Biosciences of California Inc is trading lower in after-market hours, having declined from earlier gains and remaining above its 20-day moving average.

21 sept. 2026, 22:35 UTC

In after-market trading, Pacific Biosciences of California Inc is roughly flat since Monday's close, reflecting routine performance near the lower end of its one-month range.

18 sept. 2026, 23:51 UTC

Pacific Biosciences of California Inc declined during after-market trading, moving lower since Friday's close and currently below its 20-day moving average.

17 sept. 2026, 20:02 UTC

Macro Event

Correlated Moves

Pacific Biosciences is sharply higher, reflecting a positive trend in the life sciences sector, alongside gains in the ARK Genomic Revolution ETF.

16 sept. 2026, 23:16 UTC

Pacific Biosciences of California Inc is trading roughly flat in after-market hours, remaining below its 20-day moving average after four consecutive higher sessions.

15 sept. 2026, 23:11 UTC

Pacific Biosciences of California is gaining in after-market trading, supported by a positive performance backdrop and four consecutive higher closes.

14 sept. 2026, 20:05 UTC

Correlated Moves

Pacific Biosciences of California is higher today, influenced by social media discussions on Tempus AI's $80 price target and broader market sentiment.

11 sept. 2026, 19:02 UTC

Pacific Biosciences of California is trading higher, continuing its recovery after three sessions of declines. No specific news was identified for the upward movement.

9 sept. 2026, 20:01 UTC

News

Pacific Biosciences of California shares are lower after UBS initiated coverage with a Neutral rating and a price target of $1.35.

8 sept. 2026, 23:56 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, despite fluctuations, and remain above their 20-day moving average.

3 sept. 2026, 19:56 UTC

Pacific Biosciences of California is lower today with no specific news. The broader market sees falling Treasury yields amid jobless claims data.

2 sept. 2026, 23:46 UTC

Pacific Biosciences of California is higher in after-market trading, despite no specific news, amid a weaker ADP payrolls report that may ease rate hike concerns.

1 sept. 2026, 23:46 UTC

Pacific Biosciences of California remained roughly flat during after-market hours. This follows five consecutive sessions of lower finishes.

31 août 2026, 20:07 UTC

Pacific Biosciences is trading lower, reflecting broader market declines amid heightened interest rate hike expectations from the Jackson Hole Economic Symposium.

28 août 2026, 23:36 UTC

Pacific Biosciences is trading higher in after-market hours, reaching a level significantly above Friday's close amid broader market pressures from rising Treasury yields.

27 août 2026, 20:07 UTC

Pacific Biosciences of California is lower today, with no specific news driving the decline. The broader market has also been down since Wednesday.

26 août 2026, 23:06 UTC

Pacific Biosciences of California traded roughly flat in after-market hours, with no specific news driving the activity. The stock remains near its one-month range's upper end.

25 août 2026, 23:01 UTC

Pacific Biosciences is lower in after-market trading, with no specific news identified. The broader market has also retreated amid falling crude oil prices.

24 août 2026, 23:01 UTC

Pacific Biosciences of California is trading higher in after-hours, recovering from an initial low and remaining above its 20-day moving average.

21 août 2026, 22:51 UTC

Correlated Moves

Shares of Pacific Biosciences of California declined in after-market trading, continuing a downward trend amid broader market weakness and rising Treasury yields.

20 août 2026, 19:51 UTC

Correlated Moves

Pacific Biosciences is lower today, reflecting broader market declines and trading near the lower end of its one-month range.

19 août 2026, 23:11 UTC

Correlated Moves

Pacific Biosciences of California shows a modest increase in after-market trading, reflecting stability amid a broader positive trend in correlated assets.

18 août 2026, 23:16 UTC

Correlated Moves

Pacific Biosciences shares declined in after-hours trading, continuing a downward trend since Tuesday's close, amid broader market sentiment reflected by the Russell 2000 Index.

17 août 2026, 19:11 UTC

News

Pacific Biosciences reported second-quarter revenue of $39 million, with shares trading higher today after initially dropping. The company is undergoing a leadership transition.

14 août 2026, 19:36 UTC

Correlated Moves

News

Pacific Biosciences reported second-quarter revenue of $39.01 million, missing estimates. Shares are trading lower amid concerns over funding constraints and adoption challenges.

13 août 2026, 23:06 UTC

Correlated Moves

Pacific Biosciences of California Inc. gained modestly in after-market trading, reflecting broader market trends seen in correlated assets.

12 août 2026, 23:41 UTC

Pacific Biosciences shares are lower in after-market hours, trading below their 20-day moving average amid easing inflation concerns and broader market conditions.

11 août 2026, 20:06 UTC

Pacific Biosciences of California is trading higher in a routine session. The stock remains below its 20-day moving average despite today's gains.

10 août 2026, 23:21 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, recovering from earlier losses and gaining since Monday's close.

Comparaison

Variation de prix

Pacific Biosciences of California Inc prévision

Objectif de Prix

By TipRanks

34.75% hausse

Prévisions sur 12 Mois

Moyen 1.9 USD 34.75%

Haut 3 USD

Bas 1.25 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

Achat

Maintien

Vente

Basé sur 5 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

128 / 339Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.